The Flexibility Papers, No. 2: Beyond Listening—Making Patient Input Matter

On October 16, 2026, FDA’s Rare Disease Innovation Hub, in collaboration with the Reagan-Udall Foundation for the FDA, convened a public meeting on The Patient Voice in Rare Disease Medical Product Development, which emphasized the importance of incorporating patient perspectives early and often throughout product development.